Aminoadamantanes containing monoterpene-derived fragments as potent tyrosyl-DNA phosphodiesterase 1 inhibitors

被引:36
|
作者
Ponomarev, Konstantin Yu. [1 ]
Suslov, Evgeniy V. [1 ]
Zakharenko, Alexandra L. [2 ]
Zakharova, Olga D. [2 ]
Rogachev, Artem D. [1 ,3 ]
Korchagina, Dina V. [1 ]
Zafar, Ayesha [4 ]
Reynisson, Johannes [4 ]
Nefedov, Andrey A. [1 ,3 ]
Volcho, Konstantin P. [1 ,3 ]
Salakhutdinov, Nariman F. [1 ,3 ]
Lavrik, Olga I. [1 ,2 ,3 ]
机构
[1] Russian Acad Sci, Siberian Branch, NN Vorozhtsov Novosibirsk Inst Organ Chem, 9 Akad Lavrentieva Ave, Novosibirsk 630090, Russia
[2] Russian Acad Sci, Siberian Branch, Novosibirsk Inst Chem Biol & Fundamental Med, 8 Akad Lavrentieva Ave, Novosibirsk 630090, Russia
[3] Novosibirsk State Univ, 2 Pirogova Str, Novosibirsk 630090, Russia
[4] Univ Auckland, Sch Chem Sci, Auckland, New Zealand
关键词
Natural products; Fluorescent assay; Tdp1; molecular modelling; Chemical space; Amine; Cytotoxicity; Adamantanes; EMPIRICAL SCORING FUNCTIONS; PROTEIN-LIGAND DOCKING; BIOLOGICAL EVALUATION; TOPOISOMERASE-I; 2-AMINOADAMANTANE DERIVATIVES; ADAMANTANE DERIVATIVES; TDP1; INHIBITORS; DATA-BANK; CANCER; CAMPTOTHECINS;
D O I
10.1016/j.bioorg.2017.12.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ability of a number of nitrogen-containing compounds that simultaneously carry the adamantane and monoterpene moieties to inhibit Tdp1, an important enzyme of the DNA repair system, is studied. Inhibition of this enzyme has the potential to overcome chemotherapeutic resistance of some tumor types. Compound (+)-3c synthesized from 1-aminoadamantane and (+)-myrtenal, and compound 4a produced from 2-aminoadamantane and citronellal were found to be most potent as they inhibited Tdp1 with IC50 values of 6 and 3.5 mu M, respectively. These compounds proved to have low cytotoxicity in colon HCT-116 and lung A-549 human tumor cell lines (CC50 > 50 mu M). It was demonstrated that compound 4a at 10 mu M enhanced cytotoxicity of topotecan, a topoisomerase 1 poison in clinical use, against HCT-116 more than fivefold and to a lesser extent of 1.5 increase in potency for A-549. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:392 / 399
页数:8
相关论文
共 50 条
  • [41] AP-site cleavage activity of tyrosyl-DNA phosphodiesterase 1
    Lebedeva, Natalia A.
    Rechkunova, Nadejda I.
    Lavrik, Olga I.
    FEBS LETTERS, 2011, 585 (04): : 683 - 686
  • [42] Substrate specificity of tyrosyl-DNA phosphodiesterase I (Tdp1)
    Raymond, AC
    Staker, BL
    Burgin, AB
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (23) : 22029 - 22035
  • [43] Virtual Screening for the Development of Dual-Inhibitors Targeting Topoisomerase IB and Tyrosyl-DNA Phosphodiesterase 1
    Cardamone, Francesca
    Pizzi, Simone
    Iacovelli, Federico
    Falconi, Mattia
    Desideri, Alessandro
    CURRENT DRUG TARGETS, 2017, 18 (05) : 544 - 555
  • [44] New Hybrid Compounds Combining Fragments of Usnic Acid and Monoterpenoids for Effective Tyrosyl-DNA Phosphodiesterase 1 Inhibition
    Dyrkheeva, Nadezhda S.
    Filimonov, Aleksandr S.
    Luzina, Olga A.
    Zakharenko, Alexandra L.
    Ilina, Ekaterina S.
    Malakhova, Anastasia A.
    Medvedev, Sergey P.
    Reynisson, Johannes
    Volcho, Konstantin P.
    Zakian, Suren M.
    Salakhutdinov, Nariman F.
    Lavrik, Olga, I
    BIOMOLECULES, 2021, 11 (07)
  • [45] Tyrosyl-DNA phosphodiesterase 1 initiates repair of apurinic/apyrimidinic sites
    Lebedeva, Natalia A.
    Rechkunova, Nadejda I.
    El-Khamisy, Sherif F.
    Lavrik, Olga I.
    BIOCHIMIE, 2012, 94 (08) : 1749 - 1753
  • [46] Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topotecan on in vivo tumor models
    Zakharenko, A. L.
    Luzina, O. A.
    Sokolov, D. N.
    Kaledin, V. I.
    Nikolin, V. P.
    Popova, N. A.
    Patel, J.
    Zakharova, O. D.
    Chepanova, A. A.
    Zafar, A.
    Reynisson, J.
    Leung, E.
    Leung, I. K. H.
    Volcho, K. P.
    Salakhutdinov, N. F.
    Lavrik, O. I.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 161 : 581 - 593
  • [47] The oligonucleotide-based fluorescence assay for the discovery of tyrosyl-DNA phosphodiesterase 2 inhibitors
    Zhang, Jian-Qiang
    Liang, Zi-Qiong
    Guo, Li-Shuang
    Wu, Ping-Ping
    Hu, De-Xuan
    Zhang, Cui-Xian
    An, Lin-Kun
    DYES AND PIGMENTS, 2024, 227
  • [48] Tyrosyl-DNA phosphodiesterase 2 (TDP2) repairs topoisomerase 1 DNA-protein crosslinks and 3′-blocking lesions in the absence of tyrosyl-DNA phosphodiesterase 1 (TDP1)
    Tsuda, Masataka
    Kitamasu, Kaito
    Kumagai, Chiho
    Sugiyama, Kazuya
    Nakano, Toshiaki
    Ide, Hiroshi
    DNA REPAIR, 2020, 91-92
  • [49] The First Berberine-Based Inhibitors of Tyrosyl-DNA Phosphodiesterase 1 (Tdp1), an Important DNA Repair Enzyme
    Gladkova, Elizaveta D.
    Nechepurenko, Ivan, V
    Bredikhin, Roman A.
    Chepanova, Arina A.
    Zakharenko, Alexandra L.
    Luzina, Olga A.
    Ilina, Ekaterina S.
    Dyrkheeva, Nadezhda S.
    Mamontova, Evgeniya M.
    Anarbaev, Rashid O.
    Reynisson, Johannes
    Volcho, Konstantin P.
    Salakhutdinov, Nariman E.
    Lavrik, Olga, I
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (19) : 1 - 16
  • [50] Structural basis for DNA 3′-end processing by human tyrosyl-DNA phosphodiesterase 1
    Fiona J. Flett
    Emilija Ruksenaite
    Lee A. Armstrong
    Shipra Bharati
    Roberta Carloni
    Elizabeth R. Morris
    C. Logan Mackay
    Heidrun Interthal
    Julia M. Richardson
    Nature Communications, 9